CLINICAL_TRIALS
trial_result
· 2021-02-16
Clinical Trial Update: Efficacy and Safety Evaluation of Sintilimab in Patients With Advanced or Metastatic Non-squamous NSCLC [Phase 3]
Summary
Phase 3 trial evaluating sintilimab for advanced/metastatic non-squamous non-small cell lung cancer completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Lung Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2021-02-16